There are 2789 resources available
1468P - POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Talia Golan
Session: ePoster Display
1534P - Patterns of care and outcomes of NTRK-fusion positive sarcomas: A retrospective and prospective cases series
Presenter: Armelle Dufresne
Session: ePoster Display
1535P - Exploring the dynamic crosstalk between immune system and genetics in a cohort of 116 completely resected gastrointestinal stromal tumors (GISTs)
Presenter: Lorena Incorvaia
Session: ePoster Display
1536P - Biological processes associated with the efficacy of sunitinib plus nivolumab in soft-tissue sarcoma: Correlative studies of the IMMUNOSARC trial of Spanish (GEIS) and Italian (ISG) sarcoma groups
Presenter: Serena Lacerenza
Session: ePoster Display
1537P - Dissecting inflammation in patients with desmoid fibromatosis to identify prognostic biomarkers
Presenter: Viviana Vallacchi
Session: ePoster Display
1538P - Germline testing of sarcoma revealed frequent mutations in genes involved in DNA repair, RNA metabolism, and epigenetic regulation
Presenter: Haicheng Gao
Session: ePoster Display
1539P - Sarcomas in the Dutch LFS population: Data from the national screening of TP53 germline mutation carriers at the Netherlands Cancer Institute
Presenter: Gijsbrecht de Wit
Session: ePoster Display
1470P - Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence
Presenter: Thatcher Heumann
Session: ePoster Display
1471P - Overall survival by BRCA and ATM mutation status in patients with metastatic pancreatic cancer: Findings from the PRIOR-2 study
Presenter: Gboyega Adeboyeje
Session: ePoster Display
1472P - Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of response to first-line therapy: The KRASCIPANC study
Presenter: Camille Evrard
Session: ePoster Display